Publication | Open Access
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs
23
Citations
9
References
2022
Year
UrologyGenitourinary CancerMedicineTherapeutic EfficacyCancer TreatmentProstatic DiseasePharmacologyPsma-specific Car-t CellsTumor MicroenvironmentProstate Cancer Models
| Year | Citations | |
|---|---|---|
Page 1
Page 1